• Study on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France

  • Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany

  • Study on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia France Poland

  • Study on Abemaciclib and Endocrine Therapy for Patients with Advanced Hormone Receptor Positive HER2 Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Safety and Effectiveness of Fostemsavir for Patients with Multi-drug Resistant HIV-1 Who Have Had Extensive Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Romania

  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study Comparing Gemcitabine and Mitomycin for Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Atropine Sulfate Eye Drops to Slow Down Myopia in European Children

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Ireland +4

  • Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands Norway

powered by